Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikkel Østergaard

Showing results (301-310 of 403) with videos related to

Pageof 41
Sort By:
The Journal of Rheumatology|October 3, 2014
Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registryLykke Midtbøll Ørnbjerg, Mikkel Østergaard, Pernille Bøyesen, et al.
Clinical and Experimental Rheumatology|November 30, 2020
Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational toolsGerd-Rüdiger Burmester, José María Álvaro-Gracia, Neil Betteridge, et al.
Annals of the Rheumatic Diseases|May 7, 2010
Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trialMerete L Hetland, Kristian Stengaard-Pedersen, Peter Junker, et al.
Annals of the Rheumatic Diseases|February 26, 2013
Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trialKim Hørslev-Petersen, Merete Lund Hetland, Peter Junker, et al.
Annals of the Rheumatic Diseases|February 19, 2014
MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trialFrank Behrens, Paul P Tak, Mikkel Østergaard, et al.
Arthritis Research & Therapy|February 26, 2016
Establishment of age- and sex-adjusted reference data for hand bone mass and investigation of hand bone loss in patients with rheumatoid arthritis treated in clinical practice: an observational study from the DANBIO registry and the Copenhagen Osteoarthritis StudyLykke Midtbøll Ørnbjerg, Mikkel Østergaard, Trine Jensen, et al.
Seminars in Arthritis and Rheumatism|February 7, 2024
Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritisMikkel Østergaard, Robert Gw Lambert, Anna Ef Hadsbjerg, et al.
Seminars in Arthritis and Rheumatism|February 7, 2024
The OMERACT whole-body MRI scoring system for inflammation in peripheral joints and entheses (WIPE) in spondyloarthritis - reference image atlas for the knee regionMikkel Østergaard, Marie Wetterslev, Anna Ef Hadsbjerg, et al.
Plos One|August 28, 2025
Low Th2 and high PD1+ TFh cells in blood predict remission after CTLA-4Ig treatment for 48 weeks in early rheumatoid arthritisTilia Selldén, Kerstin Andersson, Inger Gjertsson, et al.
Rheumatology (Oxford, England)|October 12, 2021
Tapering of TNF inhibitors in axial spondyloarthritis in routine care - 2-year clinical and MRI outcomes and predictors of successful taperingMarie Wetterslev, Stylianos Georgiadis, Inge Juul Sørensen, et al.
Pageof 41

Showing results (301-310 of 403) with videos related to

Sort By:
Pageof 41
The Journal of Rheumatology|October 3, 2014
Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registryLykke Midtbøll Ørnbjerg, Mikkel Østergaard, Pernille Bøyesen, et al.
Clinical and Experimental Rheumatology|November 30, 2020
Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational toolsGerd-Rüdiger Burmester, José María Álvaro-Gracia, Neil Betteridge, et al.
Annals of the Rheumatic Diseases|May 7, 2010
Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trialMerete L Hetland, Kristian Stengaard-Pedersen, Peter Junker, et al.
Annals of the Rheumatic Diseases|February 26, 2013
Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trialKim Hørslev-Petersen, Merete Lund Hetland, Peter Junker, et al.
Annals of the Rheumatic Diseases|February 19, 2014
MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trialFrank Behrens, Paul P Tak, Mikkel Østergaard, et al.
Arthritis Research & Therapy|February 26, 2016
Establishment of age- and sex-adjusted reference data for hand bone mass and investigation of hand bone loss in patients with rheumatoid arthritis treated in clinical practice: an observational study from the DANBIO registry and the Copenhagen Osteoarthritis StudyLykke Midtbøll Ørnbjerg, Mikkel Østergaard, Trine Jensen, et al.
Seminars in Arthritis and Rheumatism|February 7, 2024
Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritisMikkel Østergaard, Robert Gw Lambert, Anna Ef Hadsbjerg, et al.
Seminars in Arthritis and Rheumatism|February 7, 2024
The OMERACT whole-body MRI scoring system for inflammation in peripheral joints and entheses (WIPE) in spondyloarthritis - reference image atlas for the knee regionMikkel Østergaard, Marie Wetterslev, Anna Ef Hadsbjerg, et al.
Plos One|August 28, 2025
Low Th2 and high PD1+ TFh cells in blood predict remission after CTLA-4Ig treatment for 48 weeks in early rheumatoid arthritisTilia Selldén, Kerstin Andersson, Inger Gjertsson, et al.
Rheumatology (Oxford, England)|October 12, 2021
Tapering of TNF inhibitors in axial spondyloarthritis in routine care - 2-year clinical and MRI outcomes and predictors of successful taperingMarie Wetterslev, Stylianos Georgiadis, Inge Juul Sørensen, et al.
Pageof 41